辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝

智通财经09-29 10:28

【辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝】智通财经APP获悉，美国特拉华州一名联邦法官周一驳回了辉瑞(PFE.US)、BioNTech(BNTX.US)和Moderna(MRNA.US)提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼，该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2671262617?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-29 10:28","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2671262617","market":"us","top_or_hot":-1,"title":"辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝","media":"智通财经","content":"<html><body><div>\n<div>\n<b>【辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝】</b>智通财经APP获悉，美国特拉华州一名联邦法官周一驳回了辉瑞(PFE.US)、BioNTech(BNTX.US)和Moderna(MRNA.US)提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼，该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。                </div>\n</div></body></html>","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝\n</h2>\n\n<h4 class=\"meta\">\n\n</h4>\n\n</header>\n<article>\n<html><body><div>\n<div>\n<b>【辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝】</b>智通财经APP获悉，美国特拉华州一名联邦法官周一驳回了辉瑞(PFE.US)、BioNTech(BNTX.US)和Moderna(MRNA.US)提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼，该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。                </div>\n</div></body></html>\n\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.zhitongcaijing.com/immediately.html?type=usstock\">智通财经</a> </p>\n\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n</div>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00B19Z3581.USD","symbol_name":"Legg Mason ClearBridge - Value A Acc USD","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","article_id":"2671262617","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2671262617","pubTimestamp":1790648936,"columns":[],"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝】智通财经APP获悉，美国特拉华州一名联邦法官周一驳回了辉瑞","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU0306806265.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" ACC","LU0225771236.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (USD) INC MF","MRNY":"MRNA期权收益策略ETF-YieldMax","LU1883839398.USD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (USD) ACC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","PFE":"辉瑞","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","BK4535":"淡马锡持仓","MRNA":"Moderna, Inc.","BK4592":"伊斯兰概念","LU2596442595.SGD":"AMUNDI FUNDS INCOME OPPORTUNITIES \"A2\" (SGDHDG) INC","BK5011":"制药","GNOM":"Global X Genomics & Biotechnology ETF","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","BK4588":"碎股","BK4550":"红杉资本持仓","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","LU0306807586.USD":"SCHRODER ISF GLOBAL DIVIDEND MAXIMISER \"A\" (USD) INC QF","IDNA":"iShares Genomics Immunology and Healthcare ETF","0P6S.UK":"拜耳公司","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4548":"巴美列捷福持仓","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","MRNX":"Defiance Daily Target 2X Long MRNA ETF","LU0122379950.USD":"贝莱德世界健康科学A2","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU0225284248.USD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" ACC","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","LU0985481810.HKD":"SCHRODER ISF GLOBAL EQUITY YIELD \"A\" (HKD) INC M","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","BK4551":"寇图资本持仓","LU0321505439.SGD":"Schroder ISF Global Dividend Maximiser A Acc SGD","BK4007":"制药","LU1894683264.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) ACC","WDNA":"WisdomTree BioRevolution Fund","LU0058720904.USD":"联博国际健康护理基金A","SG9999001176.USD":"United Global Healthcare Acc USD","BK4532":"文艺复兴科技持仓","LU1894683348.USD":"AMUNDI FUNDS US EQUITY RESEARCH VALUE \"A2\" (USD) INC","BK4581":"高盛持仓","BK4599":"减肥药","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4568":"美国抗疫概念","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","BK4501":"段永平概念","LU0321505868.SGD":"Schroder ISF Global Dividend Maximiser A Dis SGD","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","BNTX":"BioNTech SE","OZEM":"Roundhill GLP-1 & Weight Loss ETF","LGHT":"LANGAR GLOBAL HEALTHTECH ETF","BK4585":"ETF&股票定投概念","SG9999002232.USD":"Allianz Global High Payout USD","BK4534":"瑞士信贷持仓","BK4139":"生物科技","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","SG9999002224.SGD":"Allianz Global High Payout SGD"},"translate_title":"Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) have had their lawsuit seeking to dismiss Bayer's Monsanto mRNA patent rejected by a judge.","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/30c8f0e27442d8e3dcfdb2109ed14298","symbols_score_info":{"WDNA":0.6,"GNOM":0.6,"PFE":1.97,"MRNA":1.96,"MRNX":0.6,"IDNA":0.6,"MRNY":0.6,"0P6S.UK":1.85,"LGHT":0.6,"BNTX":1.96,"OZEM":0.6},"content_text":"【辉瑞(PFE.US)、BioNTech(BNTX.US)、Moderna(MRNA.US)寻求驳回拜耳旗下孟山都mRNA专利诉讼遭法官拒绝】智通财经APP获悉，美国特拉华州一名联邦法官周一驳回了辉瑞(PFE.US)、BioNTech(BNTX.US)和Moderna(MRNA.US)提出的请求。这三家公司此前要求驳回德国医药巨头拜耳旗下孟山都针对它们提起的诉讼，该诉讼涉及这些制药公司对一项与mRNA技术相关专利的使用。","kind":"live","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2671262617","isCrawlerRequest":true}